Calcium salicylate-mediated apoptosis in human HT-1080 fibrosarcoma cells
J G Mahdi1, M A Alkarrawi, A J Mahdi
1School of Biosciences, Cardiff University, PO Box 911, Cardiff CF10 3US, UK. mahdijg@cf.ac.uk
Abstract:
Salicylates are novel biologically active compounds that exhibit multiple therapeutic activities. The anti-cancer effectiveness of calcium salicylate has been investigated on human HT-1080 fibrosarcoma cell lines at relatively low concentrations (predominantly 0.4 mM) compared to those previously reported. Although low calcium salicylate concentrations did not retard tumour growth progression significantly, as measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and time-lapse assays, its cytotoxic characteristics were proven to be prominent by various morphological and immunocytological techniques. The results here demonstrate evidence for approximately 25% apoptosis after treatment with calcium salicylate, which up-regulatd the expression of p53, p21 and Bax, and down-regulated Bcl-2 in HT-1080 cells.
Insights
Calcium salicylate shows significant cytotoxic effects on fibrosarcoma cells, inducing apoptosis and altering key protein expressions. While not significantly retarding tumor growth, it demonstrates potent anti-cancer properties at low concentrations.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Salicylates are biologically active compounds with diverse therapeutic applications.
- Calcium salicylate is being explored for its anti-cancer potential.
Purpose of the Study:
- To investigate the anti-cancer effectiveness of calcium salicylate on human HT-1080 fibrosarcoma cell lines.
- To evaluate the cytotoxic characteristics and molecular mechanisms of calcium salicylate at low concentrations.
Main Methods:
- Human HT-1080 fibrosarcoma cell lines were treated with calcium salicylate (predominantly 0.4 mM).
- Cell viability was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and time-lapse assays.
- Morphological and immunocytological techniques were employed to evaluate cytotoxicity and apoptosis.
- Expression levels of p53, p21, Bax, and Bcl-2 were analyzed.
Main Results:
- Low concentrations of calcium salicylate did not significantly retard tumor growth.
- Cytotoxic characteristics were prominent, with approximately 25% apoptosis observed.
- Calcium salicylate treatment upregulated the expression of p53, p21, and Bax.
- Bcl-2 expression was downregulated following calcium salicylate treatment.
Conclusions:
- Calcium salicylate exhibits significant cytotoxic effects on HT-1080 fibrosarcoma cells.
- The compound induces apoptosis through modulation of key proteins involved in cell cycle regulation and apoptosis.
- Further research into calcium salicylate as a potential anti-cancer agent is warranted.
